These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11738346)
1. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Karakoç B; Gerçeker AA Int J Antimicrob Agents; 2001 Dec; 18(6):567-70. PubMed ID: 11738346 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Güzel CB; Gerçeker AA Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363 [TBL] [Abstract][Full Text] [Related]
3. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa. Gerçeker AA; Gürler B J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946 [TBL] [Abstract][Full Text] [Related]
4. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa]. Tasaka K; Ishida A; Chinzei T Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095 [TBL] [Abstract][Full Text] [Related]
5. [Optimization of antibiotics in combination]. Zhang LH; Wang LF; Meng ZY; Yu QP; Gao BQ; Ba T; Wang XD; Ma WH; Li YY; Zhang J Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):93-6. PubMed ID: 18785405 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii. Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805 [TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates. Nazli E; Zer Y; Eksi F J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417 [TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa. Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083 [TBL] [Abstract][Full Text] [Related]
9. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa. Sood P; Mandal A; Mishra B Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa. Yasmin F; Akhtar N; Hameed A Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966 [TBL] [Abstract][Full Text] [Related]
12. Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro. Nakamura A; Hosoda M; Kato T; Yamada Y; Itoh M; Kanazawa K; Nouda H J Antimicrob Chemother; 2000 Dec; 46(6):901-4. PubMed ID: 11102407 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp. Mayer I; Nagy E J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa. Piccoli L; Guerrini M; Felici A; Marchetti F J Chemother; 2005 Aug; 17(4):355-60. PubMed ID: 16167512 [TBL] [Abstract][Full Text] [Related]
15. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve. Perea EJ; Clavijo E; Nogales MC; García Luque IG J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method]. Uete T; Matsuo K Jpn J Antibiot; 1990 Sep; 43(9):1572-8. PubMed ID: 2124633 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Song W; Woo HJ; Kim JS; Lee KM Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832 [TBL] [Abstract][Full Text] [Related]
18. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Visalli MA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819 [TBL] [Abstract][Full Text] [Related]
19. Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics. Paglia P; Molinari G; Pesce A; Debbia EA Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):639-43. PubMed ID: 2506028 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States. Sader HS; Huband MD; Castanheira M; Flamm RK Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652 [No Abstract] [Full Text] [Related] [Next] [New Search]